Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors, whereas semaglutide targets GLP-1 only and tirzepatide targets GLP-1 and GIP
Sleep quality, regular movement, meditation, and social connection all activate parasympathetic pathways and lower cortisolcreating synergy with your GLP-1 therapy
Consider Liposomal Glutathione At Cymbiotika, we offer liposomal glutathione formulations designed for optimal absorption and bioavailability
Gradual tapering allows ghrelin and hunger-related neurotransmitters to normalize more evenly, reducing the 'rebound appetite' effect that drives rapid weight regain in 70-80% of patients who stop suddenly
Ozempic is a once-weekly subcutaneous injectable medication and one of the GLP-1 medications prescribed by Calibrate clinicians
About tirzepatide Tirzepatide is a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that integrates the actions of both incretins into a single novel molecule